India to create national drugs database to address quality issues

18 November 2022
india_big

A seven-member panel has been formed by India's Ministry of Health and Family Welfare to prepare the country's first-ever national drug database, which will be used to monitor the quality of drugs in circulation, reports The Pharma Letter’s local correspondent.

Since it is not mandatory for companies to provide details, none of the government agencies have been successful in collecting accurate and robust data. The move will empower consumers and enhance monitoring, said an official.

The members of the panel include Dr HG Koshia, Commissioner of Food and Drug Control Administration (FDCA), Gujarat, Dr Pooja Gupta from AIIMS, New Delhi, Dr Jerian Jose, scientist at the Indian Council of Medical Research, New Delhi, DR Gahane, joint Commissioner of Food and Drug administration (FDA), Maharashtra, BT Khanapure, state drugs controller, Karnataka, and Navneet Marwaha, state drugs controller, Himachal Pradesh.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics